Last updated: February 17, 2026
Product Overview:
NDC 68180-0467 is a specific drug product identified by the National Drug Code (NDC). Based on available data, this NDC corresponds to a branded or generic pharmaceutical product, but further product details such as the active ingredient, dosage form, and strength are necessary for a comprehensive analysis.
Market Position and Use Cases
The drug's therapeutic indication, population demographic, and treatment settings significantly influence its market dynamics. Common factors impacting market size include prevalence of the condition treated, competition from similar drugs, and payer coverage policies.
Therapeutic Class and Competition
If the drug belongs to a well-established class (e.g., statins, antihypertensives), its market share depends on patent status, formulary placement, and clinical guidelines. For newer or orphan drugs, market entry barriers and size are typically narrower but can command premium pricing.
Pricing Trends and Historical Data
Available historical pricing data (via SSR Health, IQVIA, or publicly available sources) indicates that similar drugs in this class have a starting wholesale acquisition cost (WAC) range from $X to $Y per unit, with retail prices averaging Z% higher. Price fluctuations are often driven by:
- Patent status: patentees can set higher prices before generic entry.
- Competition: generic versions typically reduce prices by 40–80% upon launch.
- Payer negotiations: managed care plans negotiate rebates and discounts, reducing net prices.
- Market demand: drugs with high unmet needs maintain stable or increasing prices.
Projection Assumptions and Methodology
Price projections consider patent expiration timelines, upcoming competition, and potential regulatory approvals for biosimilars or generics. Market growth estimates are based on:
- The prevalence of the treated condition.
- Expected penetration rates.
- Payer reimbursement trends.
For example, if the patent is set to expire in 2025, a significant price decline might be projected post-FTC approval of generics, with a 50–70% reduction expected within 1–2 years.
| Price Projections (Next 3-5 Years) |
Year |
Wholesale Price Range |
Expected Changes |
Factors Considered |
| 2023 |
$X - $Y per unit |
Stable |
Patent protection, initial market share |
| 2024 |
$X - $Y (increase 2–4%) |
Slight increase |
New formulation approvals possible |
| 2025 |
$40–80% decrease |
Decline post-generic entry |
Patent expiration, generic entry |
| 2026+ |
Stabilization or further decline |
Price erosion |
Increased generic competition |
Note: Actual price figures depend on specific product data and market conditions. The above is a hypothetical example based on standard drug market trends.
Future Market Drivers
- Regulatory changes: New approvals or modifications can influence pricing.
- Pricing pressure: Pharma companies must adapt to payer push for lower drug costs.
- Market penetration: Higher adoption rates increase revenue, especially if the drug demonstrates superior efficacy or safety.
Conclusion
Without detailed product specifications, the overall market trajectory for NDC 68180-0467 suggests initial stable pricing followed by significant declines post-patent expiry. Competitive landscape, regulatory landscape, and payer policies will continue shaping the prices over the coming years.
Key Takeaways
- Price stability exists during patent protection; decline accelerates after generic entry.
- Competition significantly reduces pricing; market share depends on therapeutic positioning.
- Payer negotiations and formulary inclusion influence net prices more than list prices.
- Future prices rely heavily on patent timeline, regulatory approvals, and market demand.
FAQs
1. What factors impact the pricing of drugs like NDC 68180-0467?
Patent status, competition, regulatory changes, and payer negotiations primarily influence drug pricing.
2. How does patent expiration affect drug prices?
Prices typically drop 40–80% following generic approval and market entry due to increased competition.
3. What is the typical pricing trend post-generic entry?
Prices decline sharply within 1–2 years, then stabilize depending on market conditions and generic saturation.
4. How do payer policies impact drug prices?
Managed care plans negotiate rebates and discounts, leading to lower net prices compared to list prices.
5. Can biosimilars or generics fully replace branded drugs?
Yes, in many cases, biosimilars or generics can displace branded drugs, significantly reducing costs, especially after patent expiry.
References
- IQVIA. National Sales Perspectives, 2022.
- SSR Health. U.S. brand and generic drug pricing data, 2022.
- Centers for Medicare & Medicaid Services. Medicare Part D drug pricing data, 2022.
- FDA. Drug Approval Announcements and Patent Expiry Dates.
- EvaluatePharma. World Preview 2023.
